Century Huatong, Yiling Pharmaceutical and Longli Bio were listed on the Shenzhen Stock Exchange's SME Board (VC314)

On July 28, Zhejiang Century Huatong Automobile Co., Ltd., Shijiazhuang Yiling Pharmaceutical Co., Ltd. and Shandong Longli Biotechnology Co., Ltd. were listed on the Shenzhen Stock Exchange's small and medium-sized board. "And" 002604 ".

The issue price of Century Huatong is 23 yuan per share, which corresponds to an issue price-earnings ratio of 25.61 times. The number of shares issued this time was 45 million shares, and the total share capital after the issuance was 1.175 billion shares. The company is mainly engaged in the research and development, manufacturing and sales of various automotive plastic parts and related molds.

The issue price of Ling Pharmaceutical is 34.56 yuan / share, which corresponds to a price-earnings ratio of 47.39 times. The number of shares issued this time is 65 million shares, and the total share capital after the issuance is 425 million shares. The company is committed to R & D, production and sales of Chinese patent medicines. It is a national high-tech enterprise and an enterprise technology center recognized by the five national ministries and commissions. It mainly produces cardiocerebrovascular oral Chinese patent medicines and has patented varieties such as Tongxinluo capsules.

The issue price of Longli Bio is 21.5 yuan / share, corresponding to the issue price-earnings ratio of 47.78 times. The number of shares issued this time is 46.6 million shares, and the total share capital after the issuance is 186.4 million shares. The company's main business is to use corncob and corn as raw materials, adopt modern bioengineering technology to produce functional sugar, starch and starch sugar and other products, and recycle the corncob waste residue produced in the production of functional sugar to produce new generation of fuel ethanol and other new Energy products. According to reports, in May 2003, Longli Biotechnology received a capital injection of 10.21 million yuan from Shandong Hi-tech; in April 2007, Shandong High-tech Investment once again injected 14.294 million yuan into Longli Biotechnology; in September 2008, Longli Biotechnology received a Dehua Chuang Invested 16.4 million yuan in venture capital. As of before the listing, the exit return of Dehua Venture Capital was 1,450,744,000 yuan, with an exit return rate of 7.846 times; the exit return of Shandong High-tech Investment was 6,221.412 million yuan, with an exit return rate of 24.389 times.

The above information source "Venture Investment" is authorized by the China Venture Capital Research Institute (CVCRI) to publish it. All rights reserved. Please indicate the source when reprinting.

Bistro Chair And Table

After a hard working day, you went home, Pour a glass of wine, Seating on the bistro chair and table, peering ahead, find opportunities for encounter your mind.

Transform your outdoor space with our range of bistro tables, chairs & sets at golden eagle. We have something to suit every household - find charming, compact bistro tables for city balconies or large rattan armchairs for big back gardens so you can stretch out and read the paper under the sun.

· UV-resistant polyethylene environmental rattan

· Powder coated strong no rust aluminum tube

· Hard all kinds of tempered glass

· Cushions with 100% waterproof fabric.

Bistro chair and table Bistro chair and table


Bistro chair and table Bistro chair and table




If you have any questions, please contact with us directly. Outdoor Sofa Furniture are produced by Golden Eagle Outdoor Furniture With High Quality and Good Appearance. Welcome you can visit our Factory.For any inquiry,Please send mail directly to us.















Bistro Chair And Table,Garden Bistro Chair And Table,Patio Bistro Chair And Table,Rattan Bistro Chair And Table

Golden Eagle Outdoor Furniture Co., LTD. , https://www.gegardenfurnitures.com

Posted on